Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Prognosis
141 results:

  • 1. Cellular senescence is associated with the spatial evolution toward a higher metastatic phenotype in colorectal cancer.
    Park SS; Lee YK; Choi YW; Lim SB; Park SH; Kim HK; Shin JS; Kim YH; Lee DH; Kim JH; Park TJ
    Cell Rep; 2024 Mar; 43(3):113912. PubMed ID: 38446659
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Primary vulvar adenocarcinoma of intestinal type: Report of two cases showing molecular similarity with colorectal adenocarcinoma.
    Mateoiu C; Palicelli A; Maloberti T; De Biase D; De Leo A; Lindh M; Bohlin KS; Stolnicu S
    Pathol Res Pract; 2024 Mar; 255():155181. PubMed ID: 38340583
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Integrative analysis of single-cell and bulk RNA seq to reveal the prognostic model and tumor microenvironment remodeling mechanisms of cuproptosis-related genes in colorectal cancer.
    Chu B; Wang Y; Yang J; Dong B
    Aging (Albany NY); 2023 Dec; 15(23):14422-14444. PubMed ID: 38078879
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. High expression of cdkn2a is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy.
    Dong Y; Zheng M; Wang X; Yu C; Qin T; Shen X
    BMC Cancer; 2023 Nov; 23(1):1097. PubMed ID: 37950153
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A novel cuproptosis-related gene prognostic signature in colon adenocarcinoma.
    Su Y; Zhang K
    Can J Physiol Pharmacol; 2023 Nov; 101(11):589-598. PubMed ID: 37698225
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. PTPN9 dephosphorylates FGFR2 pY656/657 through interaction with ACAP1 and ameliorates pemigatinib effect in cholangiocarcinoma.
    Zhao L; Liu J; Li K; Zhang C; Chen T; Liu Z; Tang Y; Hu X; Shi A; Shu L; Huang S; Lian S; Zhang M; Li H; Sun J; Yu X; Zhang Z; Zhang Z; Xu Y
    Hepatology; 2024 Apr; 79(4):798-812. PubMed ID: 37505213
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A novel investigation into an E2F transcription factor-related prognostic model with seven signatures for colon cancer patients.
    Shen X; Su Z; Dou Y; Song X
    IET Syst Biol; 2023 Aug; 17(4):187-197. PubMed ID: 37431829
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ARL4C is associated with epithelial-to-mesenchymal transition in colorectal cancer.
    Kanai R; Uehara T; Yoshizawa T; Kamakura M; Nakajima T; Kinugawa Y; Iwaya M; Asaka S; Kitazawa M; Nagaya T; Ota H
    BMC Cancer; 2023 May; 23(1):478. PubMed ID: 37237373
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comprehensive analyses of cuproptosis-related gene cdkn2a on prognosis and immunologic therapy in human tumors.
    Zhang D; Wang T; Zhou Y; Zhang X
    Medicine (Baltimore); 2023 Apr; 102(14):e33468. PubMed ID: 37026918
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis.
    Qin Y; Liu Y; Xiang X; Long X; Chen Z; Huang X; Yang J; Li W
    Mol Cancer; 2023 Mar; 22(1):59. PubMed ID: 36959665
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma.
    Yang HD; Jin XX; Gu BB; Yu-Zhang ; Li D; Yan LL
    BMC Gastroenterol; 2023 Feb; 23(1):48. PubMed ID: 36823542
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. HPV virus and biomarkers of resistance to chemoradiation in circulating tumor cells from patients with squamous cell carcinoma of the anus.
    Ruano APC; de Jesus Ferreira Costa D; Braun AC; Torres JA; Barbosa PHP; Abdallah EA; Barberan C; Souza E Silva V; Bovolim G; Buim MEC; da Silva Alves V; Riechelmann RP; Chinen LTD
    Pathol Res Pract; 2023 Mar; 243():154327. PubMed ID: 36731178
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic significance of p16, p21, and Ki67 expression at the invasive front of colorectal cancers.
    Kin R; Hoshi D; Fujita H; Kosaka T; Takamura H; Kiyokawa E
    Pathol Int; 2023 Feb; 73(2):81-90. PubMed ID: 36484761
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The genetic alterations of rectal neuroendocrine tumor and indications for therapy and prognosis: a systematic review.
    Li K; Liu Y; Han J; Gui J; Zhang X
    Endocr J; 2023 Feb; 70(2):197-205. PubMed ID: 36403965
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Abnormal Expression of N6-Methyladenosine RNA Methylation Regulator IGF2BP3 in Colon cancer Predicts a Poor prognosis.
    Wu T; Zhang X; Xing L; Pan D; Liu P; Ding R; Yang R; Yang X; Li Y
    Dis Markers; 2022; 2022():5883101. PubMed ID: 35677634
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Identification and validation of EMT-immune-related prognostic biomarkers cdkn2a, CMTM8 and ILK in colon cancer.
    Kang N; Xie X; Zhou X; Wang Y; Chen S; Qi R; Liu T; Jiang H
    BMC Gastroenterol; 2022 Apr; 22(1):190. PubMed ID: 35429970
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Role of Autophagy in Tumor Immune Infiltration in colorectal cancer.
    Bian-Fang Y; Dong-Ning W; Dan T; Jian-Yu S; Shi-Yi W; Ben-Jun W; Xin D; Wen-Wen Z; Qing-Feng W; Yan Z
    Anal Cell Pathol (Amst); 2022; 2022():2055676. PubMed ID: 35321516
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mesothelioma and colorectal cancer: Report of Four Cases with Synchronous and Metachronous Presentation.
    Serio G; Pezzuto F; Fortarezza F; Marzullo A; Delfino MC; d'Amati A; Romano DE; Maniglio S; Caporusso C; Lettini T; Cavone D; Vimercati L
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269773
    [TBL] [Abstract] [Full Text] [Related]  

  • 19.
    Lee CC; Kuo YC; Hu JM; Chang PK; Sun CA; Yang T; Li CW; Chen CY; Lin FH; Hsu CH; Chou YC
    World J Gastroenterol; 2021 Sep; 27(34):5737-5752. PubMed ID: 34629798
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Progressive alteration of DNA methylation of Alu, MGMT, MINT2, and TFPI2 genes in colonic mucosa during colorectal cancer development.
    Kang B; Lee HS; Jeon SW; Park SY; Choi GS; Lee WK; Heo S; Lee DH; Kim DS
    Cancer Biomark; 2021; 32(2):231-236. PubMed ID: 34092617
    [TBL] [Abstract] [Full Text] [Related]  


    of 8.